99.67
price down icon1.96%   -1.99
after-market After Hours: 99.67
loading
Abbott Laboratories stock is traded at $99.67, with a volume of 9.24M. It is down -1.96% in the last 24 hours and up +12.74% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
See More
Previous Close:
$101.66
Open:
$100.52
24h Volume:
9.24M
Relative Volume:
0.68
Market Cap:
$173.61B
Revenue:
$46.59B
Net Income/Loss:
$5.41B
P/E Ratio:
32.22
EPS:
3.0938
Net Cash Flow:
$7.38B
1W Performance:
+12.04%
1M Performance:
+12.74%
6M Performance:
-17.44%
1Y Performance:
-19.89%
1-Day Range:
Value
$99.34
$101.83
1-Week Range:
Value
$87.64
$102.46
52-Week Range:
Value
$81.97
$137.49

Abbott Laboratories Stock (ABT) Company Profile

Name
Name
Abbott Laboratories
Name
Phone
(224) 667-6100
Name
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Employee
115,000
Name
Twitter
@AbbottNews
Name
Next Earnings Date
2026-07-16
Name
Latest SEC Filings
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ABT icon
ABT
Abbott Laboratories
99.67 177.07B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
314.58 122.35B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
82.35 106.61B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
43.19 65.06B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
84.55 48.94B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-22-26 Downgrade Daiwa Securities Outperform → Neutral
Oct-10-25 Initiated The Benchmark Company Buy
Jul-18-25 Upgrade Jefferies Hold → Buy
Jun-16-25 Initiated Leerink Partners Market Perform
Oct-08-24 Initiated Oppenheimer Outperform
Sep-19-24 Initiated Piper Sandler Overweight
Jul-30-24 Downgrade Edward Jones Buy → Hold
May-30-24 Initiated Goldman Buy
Jul-21-23 Upgrade Wolfe Research Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-20-23 Reiterated Barclays Overweight
Apr-20-23 Reiterated Bernstein Outperform
Apr-20-23 Reiterated JP Morgan Overweight
Apr-20-23 Reiterated Raymond James Outperform
Apr-20-23 Reiterated UBS Buy
Apr-20-23 Reiterated Wolfe Research Underperform
Mar-29-23 Initiated UBS Buy
Oct-26-22 Initiated Mizuho Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-06-22 Initiated Wolfe Research Underperform
Mar-02-22 Resumed BofA Securities Buy
Jan-27-22 Reiterated Credit Suisse Outperform
Jan-27-22 Reiterated Morgan Stanley Overweight
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated UBS Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-27-21 Upgrade Atlantic Equities Neutral → Overweight
Oct-14-21 Initiated Redburn Neutral
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Jan-28-21 Upgrade BTIG Research Neutral → Buy
Sep-11-20 Initiated Wolfe Research Outperform
Jun-01-20 Downgrade Goldman Neutral → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-02-20 Downgrade Guggenheim Buy → Neutral
Jun-13-19 Reiterated BofA/Merrill Buy
Feb-07-19 Reiterated BofA/Merrill Buy
Jan-02-19 Downgrade Citigroup Neutral → Sell
Nov-30-18 Upgrade Goldman Neutral → Buy
Oct-16-18 Initiated Barclays Overweight
Jun-27-18 Initiated Bernstein Outperform
Jan-30-18 Reiterated Citigroup Neutral
Jan-25-18 Reiterated Stifel Buy
Jan-25-18 Upgrade William Blair Mkt Perform → Outperform
Jan-03-18 Initiated Evercore ISI Outperform
Jan-02-18 Upgrade JP Morgan Neutral → Overweight
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-19-17 Reiterated RBC Capital Mkts Outperform
Oct-19-17 Reiterated Stifel Buy
View All

Abbott Laboratories Stock (ABT) Latest News

pulisher
11:00 AM

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories - Yahoo Finance

11:00 AM
pulisher
09:00 AM

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

09:00 AM
pulisher
Jul 20, 2026

Lobbying Update: $1,150,000 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen - Ad-hoc-news.de

Jul 20, 2026
pulisher
Jul 20, 2026

Craneware, Abbott Probe Separate Health Data Theft Incidents - BankInfoSecurity

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories (NYSE:ABT) Faces A Major Medical Device Growth Test - Kalkine Media

Jul 20, 2026
pulisher
Jul 20, 2026

ShinyHunters hit medial giant Abbott, disrupting cancer drug research and more - Yahoo Tech

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Investigating Cyberattack Claims From Two Threat Actors - The HIPAA Journal

Jul 20, 2026
pulisher
Jul 20, 2026

Healthcare giant Abbott probes two cyber incidents amid extortion claims - Malwarebytes

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories investigates 2 separate cyber incidents - SC Media

Jul 20, 2026
pulisher
Jul 20, 2026

Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - LinkedIn

Jul 20, 2026
pulisher
Jul 20, 2026

Benchmark reiterates Buy on Abbott Labs stock, cites guidance raise - Investing.com

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories stock trades steady as diagnostics and medical devices support growth - Ad-hoc-news.de

Jul 20, 2026
pulisher
Jul 20, 2026

Cybersecurity News: Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - CISO Series

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories Cybersecurity Breach Analysis: ShinyHunters Attack on Exact Sciences Systems and ShadowByt3$ LabCentral Portal Incident - Rescana

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Investigates Two Separate Cyber Incidents, Says No Operations Affected - Insurance Journal

Jul 20, 2026
pulisher
Jul 18, 2026

Abbott Laboratories stock holds firm as diagnostics and medical devices support earnings - ad-hoc-news.de

Jul 18, 2026
pulisher
Jul 18, 2026

Medical giant Abbott investigates two cyber incidents as ShinyHunters claims breach - Cybernews

Jul 18, 2026
pulisher
Jul 18, 2026

This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year - The Motley Fool

Jul 18, 2026
pulisher
Jul 18, 2026

Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative - simplywall.st

Jul 18, 2026
pulisher
Jul 18, 2026

Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT) - The Globe and Mail

Jul 18, 2026
pulisher
Jul 17, 2026

Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT) - Seeking Alpha

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Just Showed Its Growth Engine Has More Than One Cylinder - Trefis

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two separate cyber incidents, says no operations affected By Reuters - Investing.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two cyber intrusions targeting cancer diagnostics and LabCentral portal - Межа. Новини України.

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two separate cyber incidents, says no operations affected - Reuters

Jul 17, 2026
pulisher
Jul 17, 2026

Keysight Invalidates IRS Rule On GILTI, Abbott Says - Law360

Jul 17, 2026
pulisher
Jul 17, 2026

US companies face rise in cyber attacks - Reuters

Jul 17, 2026
pulisher
Jul 17, 2026

Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott probes two cyber incidents amid extortion claims - BleepingComputer

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott discloses cyberattack on cancer diagnostics business - MedTech Dive

Jul 17, 2026
pulisher
Jul 17, 2026

ABT Reiterated by Piper Sandler -- Price Target Raised to $118 - GuruFocus

Jul 17, 2026
pulisher
Jul 17, 2026

Can Abbott Laboratories (NYSE:ABT) Extend Its Dividend Strength? - Kalkine Media

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance - TIKR.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories Stock (ABT) Moved Up by 3.03% on Jul 17: Drivers Behind the Movement - TradingKey

Jul 17, 2026
pulisher
Jul 17, 2026

ABT Q2 Earnings Call Flags Stronger Second-Half Setup - The Globe and Mail

Jul 17, 2026
pulisher
Jul 17, 2026

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results - Benzinga

Jul 17, 2026
pulisher
Jul 17, 2026

Benchmark reiterates Buy on Abbott Labs stock, keeps $120 target - Investing.com

Jul 17, 2026
pulisher
Jul 17, 2026

Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Can Abbott Stock Deliver on Its Second-Half Growth Promise? - Trefis

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories stock could rise 40%+ by 20... - Pluang

Jul 17, 2026
pulisher
Jul 17, 2026

JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating - marketscreener.com

Jul 17, 2026
pulisher
Jul 17, 2026

Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating - marketscreener.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories: Pick Up This Dividend King Deal Now - Seeking Alpha

Jul 17, 2026
pulisher
Jul 17, 2026

Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation - NAI500

Jul 17, 2026
pulisher
Jul 17, 2026

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street - Investing.com

Jul 17, 2026
pulisher
Jul 17, 2026

What Helped Abbott Laboratories (NYSE:ABT) Raise Full-Year Outlook? - Kalkine Media

Jul 17, 2026
pulisher
Jul 16, 2026

Abbott Laboratories (ABT) Could Be 15% Undervalued On Raised 2026 Earnings Outlook - simplywall.st

Jul 16, 2026
pulisher
Jul 16, 2026

Why Abbott Stock Jumped Today - The Motley Fool

Jul 16, 2026
pulisher
Jul 16, 2026

Abbott Laboratories Earnings Call Signals Broad-Based Momentum - TipRanks

Jul 16, 2026
pulisher
Jul 16, 2026

ABT: Abbott Laboratories Exceeds Revenue and EPS Expectations, R - GuruFocus

Jul 16, 2026

Abbott Laboratories Stock (ABT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
SYK SYK
$314.58
price down icon 1.43%
MDT MDT
$82.35
price down icon 1.13%
BSX BSX
$43.19
price down icon 1.33%
EW EW
$84.55
price down icon 0.53%
$74.75
price down icon 1.24%
Cap:     |  Volume (24h):